Contract award notice
Results of the procurement procedure
Section I: Contracting
entity
I.1) Name and addresses
Western Health and Social Care Trust
Londonderry
UK
Contact person: Bronagh Hegarty
Telephone: +44 2871345171
E-mail: Bronagh.Hegarty@westerntrust.hscni.net
NUTS: UKN
Internet address(es)
Main address: https://westerntrust.hscni.net/
I.4) Type of the contracting authority
Body governed by public law
I.5) Main activity
Health
Section II: Object
II.1) Scope of the procurement
II.1.1) Title
Bristol Myers Squibb - WT2024-28 - POMALIDOMIDE (1mg, 2 mg, 3mg, 4mg) Capsules
Reference number: WT2024-28
II.1.2) Main CPV code
33600000
II.1.3) Type of contract
Supplies
II.1.4) Short description
Supply of POMALIDOMIDE (1mg, 2 mg, 3mg, 4mg) Capsules to meet clinical need in the Western Trust until 22/09/2025.
II.1.6) Information about lots
This contract is divided into lots:
No
II.1.7) Total value of the procurement
Value excluding VAT:
179 190.00
GBP
II.2) Description
II.2.3) Place of performance
NUTS code:
UKN
II.2.4) Description of the procurement
Supply of POMALIDOMIDE (1mg, 2 mg, 3mg, 4mg) Capsules to meet clinical need in the Western Trust until 22/09/2025.
II.2.5) Award criteria
Price
II.2.11) Information about options
Options:
No
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Section IV: Procedure
IV.1) Description
IV.1.1) Type of procedure
Award of a contract without prior publication of a call for competition
Justification for selected award procedure:
The works, supplies or services can be provided only by a particular economic operator for the following reason: protection of exclusive rights, including intellectual property rights
Explanation
Regulation 32(2)(b)iii permits the award of a public contract by a negotiated procedure without prior publication where the works, supplies or services can only be supplied by a particular economic operator due to the protection of exclusive rights, including intellectual property rights. The absence of competition is not the result of an artificial narrowing down of the parameters of the procurement.
The Western Health and Social Care Trust requires the purchase of POMALIDOMIDE (1mg, 2 mg, 3mg, 4mg) Capsules which are subject to patent protection / Sole MA Holder and consequently no reasonable alternative of substitute exists.
IV.1.8) Information about Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement:
Yes
Section V: Award of contract
Contract No: WT2024-28
Title: Bristol Myers Squibb - WT2024-28 - POMALIDOMIDE (1mg, 2 mg, 3mg, 4mg) Capsules
A contract/lot is awarded:
Yes
V.2 Award of contract
V.2.1) Date of conclusion of the contract
23/09/2024
V.2.2) Information about tenders
Number of tenders received: 1
The contract has been awarded to a group of economic operators:
No
V.2.3) Name and address of the contractor
BRISTOL-MYERS SQUIBB PHARMACEUTICALS LIMITED
02487574
NEW DENHAM, BUCKINGHAMSHIRE
UK
NUTS: UKJ
The contractor is an SME:
No
V.2.4) Information on value of the contract/lot (excluding VAT)
Total value of the contract/lot:
: 179 190.00
GBP
V.2.5) Information about subcontracting
Section VI: Complementary information
VI.4) Procedures for review
VI.4.1) Review body
Western Health and Social Care Trust
Londonderry
UK
VI.5) Date of dispatch of this notice
10/10/2024